One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The JID: A Scientific Home for Innovative, Rigorously Conducted, Clinical, and Epidemiologic Research in Dermatology from Around the World
Joel M.Gelfand
Toward Cannabinoid Use for Refractory Cutaneous Dermatomyositis
MiriamWittmann1PetraStaubach1DennisMcGonagle23
Platelet Plugs Prevent Vascular Hemorrhage at Sites of Neutrophil Diapedesis
AlexVargas1Scott I.Simon12
Monkeypox: Considerations as a New Pandemic Looms
Matthew G.Brewer1Stephanie R.Monticelli23Brian M.Ward4
Wound-Induced Hair Neogenesis Model
YingchaoXue1Chae HoLim23Maksim V.Plikus4567MayumiIto23GeorgeCotsarelis8Luis A.Garza1910
miR-10a, miR-30c, and miR-451a Encapsulated in Small Extracellular Vesicles Are Prosenescence Factors in Human Dermal Fibroblasts
Jae KyungLee1Soo-JinOh1Jeong-AnGim2Ok SarahShin1
Aging-Conferred SIRT7 Decline Inhibits Rosacea-Like Skin Inflammation by Modulating Toll-Like Receptor 2‒NF-κB Signaling
GuoLi1XiaolongTang239ShupingZhang1ZhiliDeng1456BenWang1WeiShi1HongfuXie145BaohuaLiu237JiLi145689
Advanced Glycation End Products Promote Melanogenesis by Activating NLRP3 Inflammasome in Human Dermal Fibroblasts
JiaqiFang12MengtingOuyang12YingyingQu12MengyaoWang1XianyinHuang1JingjingLan1WeiLai1QingfangXu1
Aberrant Wnt Signaling Induces Comedo-Like Changes in the Murine Upper Hair Follicle
WeiShang1Alvin Yong QuanTan1Maurice A.M.van Steensel12XinhongLim1
Sox9 Is Required for Nail-Bed Differentiation and Digit-Tip Regeneration
MiguelLao1AliciaHurtado12AlejandroChacón de Castro1MiguelBurgos1RafaelJiménez13Francisco J.Barrionuevo13
Mitochondrial Activity Is Upregulated in Nonlesional Atopic Dermatitis and Amenable to Therapeutic Intervention
GeraldineLeman1PetraPavel1MartinHermann2DebraCrumrine3Peter M.Elias3DeborahMinzaghi1DominiqueGoudounèche4Natalia M.Roshardt Prieto1MariaCavinato5AndreaWanner1StefanBlunder1RobertGruber1PidderJansen-Dürr5SandrineDubrac1
OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis
Yan-ZhouHuang12Yu-XinZheng12YuanZhou12FanXu1Ying-ZheCui1Xue-YanChen1Zhao-YuanWang1Bing-XiYan1MinZheng1Xiao-YongMan1
Predictors of QOL in Patients with Alopecia Areata
MaryanneSenna1JustinKo2MarcGlashofer3ChloeWalker1SusanBall4EmilyEdson-Heredia4BaojinZhu4JerryShapiro5
Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial
Victoria P.Werth12EmilyHejazi12Sandra M.Pena12JessicaHaber12MajidZeidi12NithinReddy12JoyceOkawa12RuiFeng3Muhammad M.Bashir12KirubelGebre12Arvin S.Jadoo12Josef Symon S.Concha12NancyDgetluck4ScottConstantine4BarbaraWhite4
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases
CharlieBridgewood1MiriamWittmann123TomMacleod1AbdullaWatad1456DarrenNewton7KanchanBhan8HowardAmital45GiovanniDamiani91011SamiGiryes11213Nicola LuigiBragazzi114DennisMcGonagle12
IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis
Se YunCheon126Jong HoPark126Amir H.Ameri12Richard T.Lee3Rosalynn M.Nazarian4ShadmehrDemehri12
Transcription Factor EGR1 Regulates the Expression of the Clock Gene PER2 under IL-4 Stimulation in Human Keratinocytes
HyunjinYeo1Sung ShinAhn1EuitaekJung1YoonghoLim2Young HanLee1Soon YoungShin1
Biallelic Variants in Lanosterol Synthase (LSS) Cause Palmoplantar Keratoderma-Congenital Alopecia Syndrome Type 2
FangYang1234510XingyuanJiang12310YuhaoZhu6MingyangLee123ZhengrenXu6JianglinZhang45QianLi7Mao-yingLin8HuijunWang911ZhimiaoLin18911
Human-Induced Pluripotent Stem Cell‒Derived Keratinocytes, a Useful Model to Identify and Explore the Pathological Phenotype of Epidermolysis Bullosa Simplex
JulienCoutier16ManonBonnette236SabrinaMartineau23AurélieMercadier1SophieDomingues1ManoubiaSaidani1MargotJarrige1HélènePolveche1AnnabelleDarle1NathalieHolic23SmailHadj-Rabia45ChristineBodemer45GillesLemaitre23CécileMartinat2ChristineBaldeschi23
Vγ2+ γδ T Cells in the Presence of Anti-CD40L Control Surgical Inflammation and Promote Skin Allograft Survival
ShilpiGiri1Heikrujam ThoihenMeitei1AmritaMishra1GirdhariLal1
C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fcγ Receptor Expression on Neutrophils
Daniel LeonardSeiler12MarieKleingarn1Katja HendrikaKähler1CarolineGruner1JovanSchanzenbacher1ElviraEhlers-Jeske1SamyrKenno1Christian DavidSadik34EnnoSchmidt345KatjaBieber345JörgKöhl16Ralf J.Ludwig345Christian MarcelKarsten1
Confocal Real-Time Analysis of Cutaneous Platelet Recruitment during Immune Complex‒Mediated Inflammation
Silke M.Currie17Rebekka I.Stegmeyer17KarinaMildner2LeonhardBreitsprecher3DagmarZeuschner2Olympia EkateriniPsathaki3KerstinSchäfer1MarkusWilkens1StefanVolkery4BernhardNieswandt56DietmarVestweber1
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort
Gregory A.Chang127EricRobinson127Jennifer M.Wiggins127YilongZhang234Jyothirmayee S.Tadepalli12Christine N.Schafer12FarbodDarvishian25Russell S.Berman26RichardShapiro26YongzhaoShao23ImanOsman12DavidPolsky125
Ablation of Proton/Glucose Exporter SLC45A2 Enhances Melanosomal Glycolysis to Inhibit Melanin Biosynthesis and Promote Melanoma Metastasis
YeLiu17WennaChi127LeiTao12GuoqiangWang1R.N.V. KrishnaDeepak3LinlinSheng1TaiqiChen4YaqianFeng1XizhiCao1LiliCheng1XinbinZhao1XiaohuiLiu5HaitengDeng5HaoFan3PengJiang4LigongChen12
Staphylococcus epidermidis-Derived Protease Esp Mediates Proteolytic Activation of Pro‒IL-1β in Human Keratinocytes
FranziskaRademacher1JoachimBartels1RegineGläser1MenoRodewald1SabineSchubert2DanielDrücke3HolgerRohde4JürgenHarder1
Longitudinal Characterization of the Fungal Skin Microbiota in Healthy Subjects Over a Period of 1 Year
BettinaSchmid1AxelKünstner2AnkeFähnrich2HaukeBusch2MartinGlatz1Philipp P.Bosshard1
Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma
Anita Y.Voigt1AkintundeEmiola1Jethro S.Johnson12Elizabeth S.Fleming1HoanNguyen1WeiZhou1Kenneth Y.Tsai34ChristineFink5JuliaOh1
Merkel Cell Carcinoma Sensitivity to EZH2 Inhibition Is Mediated by SIX1 Derepression
Ashley K.Gartin12Thomas C.Frost12Camille H.Cushman12Brittaney A.Leeper34Prafulla C.Gokhale34James A.DeCaprio125
Circular RNA Signatures of Human Healing and Nonhealing Wounds
Maria A.Toma127ZhuangLiu1278QizhangWang123LetianZhang12DongqingLi124PehrSommar5Ning XuLandén1268
γδ T Cell‒Mediated Wound Healing Is Diminished by Allergic Skin Inflammation
JocelynWang124AbigailPajulas14YongyaoFu1DjamilatouAdom1WenwuZhang1Andrew S.Nelson12Dan F.Spandau13Mark H.Kaplan12
The Psoriasis Glycome: Differential Expression of Cholesterol Particle Glycans and IgA Glycans Linked to Disease Severity
EmanualMaverakis18WilliamLiakos18DayoungPark23ForumPatel1FarihaSiddiqui1Muchena J.Kailemia2L. ReneeRuhaak4Alina I.Marusina1GuillaumeLuxardi1Johann E.Gudjonsson5Stephanie T.Le1April W.Armstrong6WilsonLiao7Alexander A.Merleev1Carlito B.Lebrilla2
The Double-Stranded RNA Analog, Poly(I:C), Triggers Distinct Transcriptomic Shifts in Keratinocyte Subsets
KeikoSakamoto1KeisukeNagao1
Identification of Genetic Loci Associated with Facial Wrinkles in a Large Korean Population
Seo-GyeongLee1Joong-GonShin1YunkwanKim1SangseobLeem1Sun GyooPark1Hong-HeeWon23Nae GyuKang13
In Vivo Imaging of CD8+ T-Cell‒Mediated Keratinocyte Apoptosis in Graft-Versus-Host Disease‒Like Dermatitis in Involucrin Membrane-Bound Ovalbumin Mice
Hui MeiCheng12TetsuyaHonda13RyotaAsahina1ToshiyaMiyake1ZacharyChow14MichioTomura4Jun-ichiSakabe35YoshikiTokura3KenjiKabashima15
A Distinct Immature Low-Density Neutrophil Population Characterizes Acute Generalized Pustular Psoriasis
NingYu123HuiQin123YingyuanYu123YingLi12JiajingLu12YulingShi12
Utility of a circulating tumor DNA test for detecting clinically evident and occult Merkel cell carcinoma
TomokoAkaike1NaomiSo2Daniel S.Hippe3LindsayGunnell1Coley Doolittle-Amieva1KristinaLachance1EvanHall4ShailenderBhatia4AlecEschholz2RichaRathore5NicoleHook5KathrynBaker5AngelRodriguez5AndrewEcklund5AlexeyAleshin5PaulNghiem1Lisa C.Zaba2
Cancer-associated fibroblasts exert a pro-angiogenic activity in Merkel cell carcinoma
SilviaAlbertini12LiciaMartuscelli2CinziaBorgogna2SanamjeetVirdi3DanielaIndenbirken3RenzoBoldorini4MarisaGariglio2NicoleFischer1
Milademetan is a highly potent MDM2 inhibitor in TP53 wild-type (p53 WT) models of Merkel cell carcinoma (MCC)
VarshaAnanthapadmanabhan12Thomas C.Frost13Kara M.Soroko4AineKnott4BriannaMagliozzi4Prafulla C.Gokhale4VijayaTirunagaru5Robert C.Doebele5James A.DeCaprio123
Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy
RashmiBhakuni1Peter H.Goff2Jung HyunLee1ThomasPulliam1Shira Tabachnick-Cherny1Carina D.Morningstar1PaulNghiem1
Phase 2 Study of Intratumoral Vidutolimod With Intravenous Cemiplimab in Patients With Locally Advanced or Metastatic Merkel Cell Carcinoma (CMP-001- 009)
ShailenderBhatia1John R.Hyngstrom2AlexandraIkeguchi3Sajeve S.Thomas4Ann W.Silk5DmitriBobilev6LupingZhao6James E.Wooldridge6Arthur M.Krieg6DiwakarDavar7
ADAM Trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in Merkel cell carcinoma patients with lymph node metastases; NCT03271372
WenwenChen1∗ShailenderBhatia1Andrew S.Brohl2SunandanaChandra3SumiaDakhil1Leslie A.Fecher4LingGao5Ted A.Gooley6Glenn J.Hanna7ReinaHibbert1Ciara M.Kelly8Samantha M.Kiriluk1KarlLewis9StergiosMoschos10PaulNghiem11John A.Thompson1Scott S.Tykodi1
What is the risk of Merkel cell carcinoma recurrence beyond pathologically clear margins? An analysis of 926 cases
AlexFu1NehaSingh2KristinaLachance1DanielHippe3PaulNghiem1Song YounPark1
The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do?
Natasha T.Hill1LorenCollado1TylerKellenberger1KunioNagashima2SerenaVilasi1Paul W.Harms3IsaacBrownell1
Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy
SaumyaJani13Thomas H.Pulliam1KoshlanMayer-Blackwell4PhilipBradley5David M.Koelle23PaulNghiem13
Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation
Derin B.Keskin1Patrick C.Lee1SusanKlaeger2Phuong M.Le1KeeganKorthauer3JingweiCheng1VarshaAnanthapadmanabhan1Thomas C.Frost1J. BryanIorgulescu1Camilla K.Lemvigh4Christina B.Pedersen4SiranushSarkizova3ShuqiangLi1XiaoxiLiu5Laura M.Doherty5DonnaNeuberg1GuanglanZhang6Lars R.Olsen4…Catherine J.Wu1
Understanding the Interaction Between Merkel Cell Polyomavirus Small T Antigen and Delta-Catenin
JoselynLandazuri12KristineDye3Nick J.H.Salisbury1AnnRoman1Denise A.Galloway1
Understanding the Influence of Patient Demographics and Socioeconomic Status in Merkel Cell Carcinoma
KyleLauck1Quoc-BaoNguyen23RohitGupta4DawenSui5Hung Q.Doan23
Postoperative radiotherapy in stage I-III Merkel cell carcinoma
SonjaLevy1Stephanie A.Blankenstein2Dirk JanGrünhagen3MathildeJalving4OlgaHamming-Vrieze5Lukas B.Been6LisaTans7Alexander C.J.van Akkooi2Margot E.T.Tesselaar8
Understanding Socioeconomic and Racial Disparities in Merkel Cell Carcinoma
MackenzieMartin1NoreenMohsin1DanielleReed1IsaacBrownell1
From database to clinic: Using a multivariable recurrence risk calculator to guide Merkel cell carcinoma surveillance
AubrianaMcEvoy12KristinaLachance1DanielHippe3MaryRedman3TedGooley3Michael W.Kattan4PaulNghiem1
Early-Onset Merkel Cell Carcinoma is Associated with Germline Defects in DNA Repair Genes and a Rare Immunodeficiency
NoreenMoshin1∗DevinHunt2∗Austin J.Jabbour3PaulNghiem4Alexandra F.Freemam5Jenna R.E.Bergerson5MorganSimiluk2KristinaLachance4RimaKulikauskas4Bryce A.Seifert2RajarshiGhosh2Magdalena A.Walkiewicz2IsaacBrownell1
Persistent seropositivity of antibodies to Merkel cell polyomavirus oncoprotein (AMERK) in patients in remission from Merkel cell carcinoma
Daniel G.Noe1Julie G.Grossman2NataliaJaimes13GeorgeElgart13ClaraMilikowski14LynnFeun15JoseLutzky15Mecker G.Möller16
An intratumoral STING agonist-mediated clinical response in PD-L1-refractory MCC via an unexpected mechanism of action
Thomas H.Pulliam1RashmiBhakuni1SaumyaJani1KimberlySmythe2BrandonSeaton2LisaTachiki3RimaKulikauskas1PaulNghiem12ShailenderBhatia23
Racial Differences in Population Demographics, Tumor Characteristics, and Overall Survival in Merkel Cell Carcinoma Patients
AbbasRattaniMD1JeremyGaskinsPhD2GrantMcKenzieMD1Virginia KateScharf3KristyBromanMD4MariaPisuPhD5AshleyHolderMD4NealDunlapMD1MehranYusufMD6
Repurposing disulfiram for the treatment of Merkel cell carcinoma
Danielle J.Reed1Natasha T.Hill1TaraGelb1DanUrban2TylerKellenberger1AnnaLin1SerenaVilasi1MatthewHall2IsaacBrownell1
Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1/PD-1- refractory Merkel Cell Carcinoma
Sophia Z.ShalhoutPhD1Kevin S.EmerickMD2Howard L.KaufmanMD3David M.MillerMD, PhD14
Defining myeloid cells in the tumor microenvironment of Merkel cell carcinoma and their role in resistance to immunotherapy
ShiraTabachnick-Cherny1ThomasPullliam1KimberlySmythe2PaulNghiem1
Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy
Lisa M.Tachiki13LaurenZawacki2Daniel S.Hippe3YasmanMoshiri2NoraAlexander2TomokoAkaike2ColeyDoolittle-Amieva2ThomasPulliam2Lisa C.Zaba4ShailenderBhatia13PaulNghiem2
Merkel polyomavirus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma
JoshuaVeatch1KellyPaulson2YutaAsano1MeganMcAfee3LaurenMartin1BoLee1EvanHall4ShailenderBhatia4PaulNghiem4AudeChapuis1
Neoadjuvant systemic therapy for Merkel cell carcinoma: A Tertiary Referral Center Experience
Russell G.Witt1BrandonCope1RiyadSeervai2Yi-JuChiang1Sarah B.Fisher1AnthonyLucci1Jeffrey E.Gershenwald1Jennifer A.Wargo1Merrick I.Ross1Michael K.Wong3DevaratiMitra2Emily Z.Keung1
Navtemadlin (KRT-232) in combination with avelumab for patients with anti-PD-1/L1 treatment-naïve TP53WT Merkel cell carcinoma (MCC)
Michael K.Wong1MelissaBurgess2SunandanaChandra3DirkSchadendorf4AnnSilk5Anthony J.Olszanski6Jean-JacquesGrob7SekwonJang8Jaspreet SinghGrewal9Karl D.Lewis10LeslieFecher11GuilhermeRabinowits12CelesteLebbe13JuanMartin-Liberal14Anna MariaDi Giacomo15PhilipFriedlander16Andrew S.Brohl17BrandonCroft18…Ciara M.Kelly19
